May 19, 2026 · 57m · sourcery
How He Turned a Blood Test Startup Into $7B OS for Healthcare · Sourcery with Molly O'Shea
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of Sourcery, host Molly O'Shea interviews Tanay Tandon, Co-Founder and CEO of Commure, about scaling healthcare's leading AI operating system to a $7 billion valuation. Tandon details Commure's enterprise expansion, non-dilutive financing model, platform strategy over point solutions, and operational playbook for transforming American healthcare efficiency.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Molly holds 22.8% of the talking time here. How this is scored →
speaking balance: gold is Molly, purple is the guest (3 minute bins)
Tanay directly and tersely pushes back on Molly's claim that he was inspired by Elizabeth Holmes, calling it an Alfred Lin jab.
Hardest push from Molly ▶ 43:04 Molly needles Tanay on blood testing originsMolly playfully challenges Tanay on his company's beginnings by asserting he was inspired by Theranos founder Elizabeth Holmes.
Biggest teaching moment ▶ 33:05 Tanay exposes healthcare data liquidity and Epic monopolyTanay gives a vivid breakdown contrasting standard enterprise software data portability in Salesforce with Epic's prohibitive data blocking.
Molly holds their own ▶ 5:41 Molly probes token cost margins against traditional SaaS modelsMolly demonstrates deep domain knowledge of venture capital finance, challenging whether rising LLM token consumption is squeezing startup gross margins.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | Molly as informed peer | Guest teaching | Guest disagreement | Molly pushing back | Why |
|---|---|---|---|---|---|---|
| Welcome & $70M Funding Announcement | 4 | 5 | 1 | 1 | Molly introduces the funding round and asks about General Catalyst's Customer Value Fund (CVF) and margin compression from LLM token usage. Tanay provides an in-depth operational explanation comparing CVF to Rockefeller-era debt financing and details his gross margin breakdown across SaaS vs services. | |
| Commure's Ambition to Go Public | 2 | 5 | 3 | 0 | Molly asks about Commure's public market ambitions and OS strategy. Tanay speaks authoritatively about health system economics, critiquing hospital administration for behaving like politicians rather than ruthless business operators. | |
| Scale, Patient Encounters & Enterprise Go-To-Market Channels | 2 | 5 | 2 | 1 | Molly asks if they touch 100M patients annually, and Tanay corrects her that it is north of 200M encounters. He outlines their distribution strategy across PLG, top-down health system agreements with HCA and Tenet, and Epic partnerships. | |
| Platform Strategy vs. The Impending Death of Point Solutions | 4 | 6 | 4 | 1 | Molly asks about managing platform complexity versus pure point solutions. Tanay aggressively dismisses VC-backed point solutions as ephemeral GPT wrappers that will be killed and disintermediated, citing historical precedents like Grammatik vs Microsoft Word. | |
| Regulatory Compliance, Evals, and AI Model Reliability | 4 | 5 | 1 | 0 | Molly draws on Theresa Carlson's insights regarding AI implementation in heavily regulated environments. Tanay elaborates on the necessity of enterprise transformation motions, test harness evaluations, and rigorous edge-case backtesting to prevent hallucination regressions. | |
| Mid-Roll Sponsor Block: Brex & Turing | 3 | 5 | 1 | 1 | Following mid-roll sponsor reads, Molly questions the viability of AI malpractice insurance and onboarding logistics. Tanay explains why malpractice risk actually drops with AI adoption and describes deploying forward-deployed engineers to hospital floors. | |
| Preventing Physician Burnout & Building An AI Hospital (SUMA Health) | 3 | 4 | 1 | 0 | Molly inquires about the changing labor composition of healthcare teams. Tanay shares a story of a physician kept from quitting through ambient charting and outlines General Catalyst's direct acquisition of SUMA Health in Ohio to build an AI hospital model. | |
| Emergency Room Nurses & Frontline Operational Realities | 3 | 3 | 1 | 0 | Molly shares an anecdote about mobile IV nurses who love high-stress ER environments. Tanay agrees, emphasizing the intense problem density of emergency triage and how engineers thrive on solving high-friction operational workflows. | |
| Healthcare Regulatory Climate, Data Liquidity, and HHS Policy | 5 | 5 | 4 | 0 | Molly asks about the regulatory stance under the current administration and connects it to an HHS official's comments. Tanay passionately attacks Epic's walled garden and data lock-in while praising DOJ enforcement of information blocking under the Cures Act. | |
| Company Culture: Being a 'Heat-Seeking Missile for Pain' | 4 | 4 | 2 | 0 | Molly quotes verbatim from Tanay's viral email shared by Alfred Lin defining employees as 'heat-seeking missiles for pain.' Tanay expounds on his core philosophy that pain is the fundamental signal and genesis of value creation in capitalism. | |
| M&A Playbook and Post-Merger Cultural Integration | 3 | 5 | 2 | 0 | Molly asks about Tanay's non-traditional M&A path. Tanay breaks down historical roll-ups (Disney, Dell, Rockefeller), the Augmedix acquisition, and the imperative of ruthlessly imposing a single acquiring culture within 45 to 90 days. | |
| Blood Testing Origins & Sponsor Block (VCX, Public, Merge, Deel) | 2 | 4 | 4 | 2 | Molly brings up Commure's blood-testing origins and provocatively suggests Tanay was inspired by Elizabeth Holmes. Tanay immediately rejects the framing, labeling it an Alfred Lin jab, before the episode enters a multi-sponsor read block. | |
| Early Startup Lore: The 'Residual Blood Samples' Hack | 3 | 3 | 1 | 0 | Molly asks about early startup lore involving Deepika. Tanay humorously recounts getting residual blood samples from hospital security guards as 19-year-olds and later turning a formal administration confrontation into a lasting commercial partnership. | |
| Transitioning to Enterprise Sales & The JP Morgan Suit Lore | 3 | 2 | 1 | 0 | Molly asks Alfred Lin's question about Tanay wearing cargo shorts and flip-flops to the JPMorgan Healthcare Conference. Tanay recounts the lesson that forced him to transition into a polished enterprise sales leader who now owns multiple suits. | |
| Working with Sequoia's Alfred Lin & GC's Hemant Taneja | 3 | 3 | 0 | 0 | Molly asks about working with Alfred Lin and Hemant Taneja. Tanay highlights Alfred's sharp operational and P&L scrutiny, his ability to close top executives, and recalls meeting Hemant as a Stanford freshman trying to park a bike through GC's fence. | |
| Hottest Take on US Healthcare & Excitement for Agentic AI | 2 | 6 | 4 | 0 | Molly asks for Tanay's hottest take and future outlook. Tanay delivers a vehement defense of US healthcare innovation against UK and Canadian systems, framing LLMs and agentic automation as his life's work to eliminate administrative work taxes. |